Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Roberto Bertollini and Adeel Butt.
Roberto Bertollini
Connection Strength
2.916
Adeel Butt
  1. Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses. J Travel Med. 2021 10 11; 28(7).
    View in: PubMed
    Score: 0.243
  2. Assessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure Setting. Clin Infect Dis. 2021 10 05; 73(7):e1830-e1840.
    View in: PubMed
    Score: 0.243
  3. Outcomes Among Patients with Breakthrough SARS-CoV-2 Infection After Vaccination. Int J Infect Dis. 2021 Sep; 110:353-358.
    View in: PubMed
    Score: 0.240
  4. SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy. EClinicalMedicine. 2021 May; 35:100861.
    View in: PubMed
    Score: 0.236
  5. Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic. Sci Rep. 2021 03 18; 11(1):6233.
    View in: PubMed
    Score: 0.234
  6. Steps and Challenges in Creating and Managing Quarantine Capacity During a Global Emergency - Qatar's Experience. J Infect Public Health. 2021 May; 14(5):598-600.
    View in: PubMed
    Score: 0.232
  7. Two prolonged viremic SARS-CoV-2 infections with conserved viral genome for two months. Infect Genet Evol. 2021 03; 88:104684.
    View in: PubMed
    Score: 0.230
  8. Impact of COVID-19 upon changes in emergency room visits with chest pain of possible cardiac origin. BMC Res Notes. 2020 Nov 18; 13(1):539.
    View in: PubMed
    Score: 0.228
  9. Epidemiological investigation of the first 5685 cases of SARS-CoV-2 infection in Qatar, 28 February-18 April 2020. BMJ Open. 2020 10 07; 10(10):e040428.
    View in: PubMed
    Score: 0.227
  10. Hospital admission rates, length of stay, and in-hospital mortality for common acute care conditions in COVID-19 vs. pre-COVID-19 era. Public Health. 2020 Dec; 189:6-11.
    View in: PubMed
    Score: 0.226
  11. Volume and Acuity of Emergency Department Visits Prior To and After COVID-19. J Emerg Med. 2020 11; 59(5):730-734.
    View in: PubMed
    Score: 0.224
  12. mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar. Nat Med. 2021 09; 27(9):1614-1621.
    View in: PubMed
    Score: 0.060
  13. SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals. iScience. 2021 Jun 25; 24(6):102646.
    View in: PubMed
    Score: 0.059
  14. SARS-CoV-2 Infection Is at Herd Immunity in the Majority Segment of the Population of Qatar. Open Forum Infect Dis. 2021 Aug; 8(8):ofab221.
    View in: PubMed
    Score: 0.059
  15. Herd Immunity against Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 10 Communities, Qatar. Emerg Infect Dis. 2021 05; 27(5):1343-1352.
    View in: PubMed
    Score: 0.059
  16. Epidemiological impact of prioritising SARS-CoV-2 vaccination by antibody status: mathematical modelling analyses. BMJ Innov. 2021 Apr; 7(2):327-336.
    View in: PubMed
    Score: 0.059
  17. Mathematical modeling of the SARS-CoV-2 epidemic in Qatar and its impact on the national response to COVID-19. J Glob Health. 2021 Jan 16; 11:05005.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.